CUTR

Cutera, Inc. (CUTR) | Rumor.io

Cutera

CUTR

Attention (50-day avg)0%

Attention rank (50-day avg)—

Bullish sentiment (50-day avg)—

Price to earnings ratio0

Market capitalization0

Earnings per share0

Dividend yield (TTM)—

Revenue (annual)0

Net income (annual)0

Social

What share of all stock conversation is about CUTR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Mar 12

Cutera, Inc. ($CUTR) is expected to be delisted from Nasdaq on or about March 30, 2025, and may be eligible for OTC quotation after restructuring.
The company's international entities, not included in the Chapter 11 bankruptcy proceedings, may provide a financial lifeline and help preserve its brand value and market position.
Cutera's goal is to get rid of $400 million of debt and secure $65 million in fresh investment, which could enable it to restart operations and potentially transition to the OTC market.

Generated by AI

Sentiment

Of the messages about CUTR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	57.53% -21.56
Bearish	—	—	—	42.47% +21.56

Bullish· Mar 11

$CUTR is due for a clean breakout above $0.28, potentially leading to further gains.
The short interest in $CUTR is low, increasing the likelihood of a short squeeze and subsequent price increase.
$CUTR has significant upside potential, with some investors expecting it to "moon" in value before delisting.

Bearish· Mar 11

$CUTR is likely to plummet to $1 or even $0.01 due to institutional buyers taking control and shorting amongst themselves.
The shorts are trapped with no exit, increasing the likelihood of a significant price drop, and the delisting deadline adds pressure to the situation.
The stock's delisting and subsequent forced liquidations could lead to a rapid price drop, with some predicting a return to $0.23 or even bankruptcy.

Generated by AI

Topics

Of the messages about CUTR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	0%
Announcements	—	—	100%	91.07%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	8.93%

Earnings· Nov 6

Cutera, Inc. ($CUTR) reported Q3 earnings of 11c EPS and $40.57M in revenue.
The company beat the Estimize EPS consensus by 1c but missed the Estimize revenue consensus by $1.69M.
Cutera's reported earnings of $0.11 per share exceeded the consensus estimate of ($0.08).

Announcements· Apr 12

Cutera, Inc. (CUTR) has terminated its CEO and executive chairman amid a succession battle and withdrawn its outlook.
The company's board has appointed Sheila Hopkins as interim CEO and Janet Widmann as independent chair, effective immediately, while searching for a permanent CEO.
The former CEO and executive chairman, David Mowry and J. Daniel Plants, have sued the company's directors and taken legal action to ensure shareholders have a say in the composition of the board and selection of the next CEO.

Technical Analysis· Mar 11

$CUTR needs a clean breakout over $0.28 to continue its upward trend.
The stock is forming a cup and handle pattern on the hourly chart, which could indicate a potential continuation of the upward trend.
$CUTR is breaking into pre-market supply and retesting its daily high, which could be a sign of a potential gap fill and continuation of the upward trend.

Generated by AI

Community

Of the messages about CUTR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	33.33%
Newcomers	—	—	100%	66.67%

Regulars· Mar 22

Cutera, Inc. (CUTR) reported a Q4 2023 earnings call transcript, with the stock currently trading down -29.16%.
The stock traded at 114% above average volume, with a decline of -27.42% and -10.87% in recent sessions.
Analysts are optimistic about Cutera's potential, with William Blair upgrading the stock to Market Perform and Stephens maintaining an Overweight rating with a $10 price target.

Newcomers· Jan 10

Newcomers are excited about Cutera's new acne laser treatment, citing great reviews and major endorsements coming.
The stock's potential for a short squeeze is discussed, with some users pointing to the large number of short positions and the company's plans to enter the mainstream acne treatment market.
Cutera's revenue growth and the company's focus on new product introductions and sales in 2024 are seen as catalysts for the stock's upside, with some users referencing the stock's historical price range of $30-$40.

Generated by AI

News

MODERN DAY WIFE RETURNS TO LOS ANGELES WITH ITS FOURTH ANNUAL SOIRÉE EN BLANC AT SOFITEL BEVERLY HILLS

A French Riviera-Inspired Celebration Brings Together Celebrity Speakers, Industry Leaders, Fashion, Beauty,

2mo agoUSA Today

Also Discussed

Investors talking about CUTR also mention

#	Name	Attention
1	InMode Ltd.INMD	0%0
2	TransCode Therapeutics, Inc.RNAZ	0%+0
3	Femto Technologies Inc.BCAN	0%0
4	Ocean Biomedical Inc.OCEA	0%0
5	TCBP - TC Biopharm (Holdings) Plc	——
6	AnaptysBio, Inc.ANAB	0%0
7	Syros Pharmaceuticals Inc.SYRS	0%0
8	MURA - Mural Oncology plc	——
9	DYNT - Dynatronics Corporation	——
10	STAAR Surgical CompanySTAA	0%new

Cutera, Inc.

Location

Social

What share of all stock conversation is about CUTR?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% 0	0% 0	0% new	0% 0

Mar 12

Cutera, Inc. ($CUTR) is expected to be delisted from Nasdaq on or about March 30, 2025, and may be eligible for OTC quotation after restructuring.
The company's international entities, not included in the Chapter 11 bankruptcy proceedings, may provide a financial lifeline and help preserve its brand value and market position.
Cutera's goal is to get rid of $400 million of debt and secure $65 million in fresh investment, which could enable it to restart operations and potentially transition to the OTC market.

Generated by AI

Sentiment

Of the messages about CUTR that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	—	—	—	57.53% -21.56
Bearish	—	—	—	42.47% +21.56

Bullish· Mar 11

$CUTR is due for a clean breakout above $0.28, potentially leading to further gains.
The short interest in $CUTR is low, increasing the likelihood of a short squeeze and subsequent price increase.
$CUTR has significant upside potential, with some investors expecting it to "moon" in value before delisting.

Bearish· Mar 11

$CUTR is likely to plummet to $1 or even $0.01 due to institutional buyers taking control and shorting amongst themselves.
The shorts are trapped with no exit, increasing the likelihood of a significant price drop, and the delisting deadline adds pressure to the situation.
The stock's delisting and subsequent forced liquidations could lead to a rapid price drop, with some predicting a return to $0.23 or even bankruptcy.

Generated by AI

Topics

Of the messages about CUTR that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Analysts	—	—	0%	0%
Announcements	—	—	100%	91.07%
Controversies	—	—	0%	0%
Earnings	—	—	0%	0%
Macro	—	—	0%	0%
Technical Analysis	—	—	0%	8.93%

Earnings· Nov 6

Cutera, Inc. ($CUTR) reported Q3 earnings of 11c EPS and $40.57M in revenue.
The company beat the Estimize EPS consensus by 1c but missed the Estimize revenue consensus by $1.69M.
Cutera's reported earnings of $0.11 per share exceeded the consensus estimate of ($0.08).

Announcements· Apr 12

Cutera, Inc. (CUTR) has terminated its CEO and executive chairman amid a succession battle and withdrawn its outlook.
The company's board has appointed Sheila Hopkins as interim CEO and Janet Widmann as independent chair, effective immediately, while searching for a permanent CEO.
The former CEO and executive chairman, David Mowry and J. Daniel Plants, have sued the company's directors and taken legal action to ensure shareholders have a say in the composition of the board and selection of the next CEO.

Technical Analysis· Mar 11

$CUTR needs a clean breakout over $0.28 to continue its upward trend.
The stock is forming a cup and handle pattern on the hourly chart, which could indicate a potential continuation of the upward trend.
$CUTR is breaking into pre-market supply and retesting its daily high, which could be a sign of a potential gap fill and continuation of the upward trend.

Generated by AI

Community

Of the messages about CUTR, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	—	—	0%	33.33%
Newcomers	—	—	100%	66.67%

Regulars· Mar 22

Cutera, Inc. (CUTR) reported a Q4 2023 earnings call transcript, with the stock currently trading down -29.16%.
The stock traded at 114% above average volume, with a decline of -27.42% and -10.87% in recent sessions.
Analysts are optimistic about Cutera's potential, with William Blair upgrading the stock to Market Perform and Stephens maintaining an Overweight rating with a $10 price target.

Newcomers· Jan 10

Newcomers are excited about Cutera's new acne laser treatment, citing great reviews and major endorsements coming.
The stock's potential for a short squeeze is discussed, with some users pointing to the large number of short positions and the company's plans to enter the mainstream acne treatment market.
Cutera's revenue growth and the company's focus on new product introductions and sales in 2024 are seen as catalysts for the stock's upside, with some users referencing the stock's historical price range of $30-$40.

Generated by AI

Cutera

Social

Mar 12

Bullish· Mar 11

Bearish· Mar 11

Earnings· Nov 6

Announcements· Apr 12

Technical Analysis· Mar 11

Regulars· Mar 22

Newcomers· Jan 10

MODERN DAY WIFE RETURNS TO LOS ANGELES WITH ITS FOURTH ANNUAL SOIRÉE EN BLANC AT SOFITEL BEVERLY HILLS

Also Discussed

Cutera, Inc.

Company Information

Location

MODERN DAY WIFE RETURNS TO LOS ANGELES WITH ITS FOURTH ANNUAL SOIRÉE EN BLANC AT SOFITEL BEVERLY HILLS

Also Discussed

Social

Mar 12

Bullish· Mar 11

Bearish· Mar 11

Earnings· Nov 6

Announcements· Apr 12

Technical Analysis· Mar 11

Regulars· Mar 22

Newcomers· Jan 10